Persistent Systemic Inflamation is Associated with Poor Clinical Outcomes in COPD: A Novel Phenotype

• Published in: PloS one 2012-04
• Main Authors: Agustí García-Navarro, Àlvar, Edwards, Lisa D, Rennard, Stephen I, MacNee, William, Tal-Singer, Ruth, Miller, Bruce E, Vestbo, Jørgen, Lomas, David A, Calverley, Peter M, Wouters, Emiel, Crim, Courtney, Yates, Julie C, Silverman, Edwin K, Coxson, Harvey O, Bakke, Per, Mayer, Ruth J, Celli, Bartolome R
• Format: Article
• Language: English
• Subjects: Assaigs clínics; Chronic obstructive pulmonary diseases; Clinical trials; Malalties de l'aparell respiratori; Malalties pulmonars obstructives cròniques; Respiratory organs diseases
• ISSN: 1932-6203; 1932-6203

BACKGROUND: Because chronic obstructive pulmonary disease (COPD) is a heterogeneous condition, the identification of specific clinical phenotypes is key to developing more effective therapies. To explore if the persistence of systemic inflammation is associated with poor clinical outcomes in COPD we assessed patients recruited to the well-characterized ECLIPSE cohort (NCT00292552). METHODS AND FINDINGS: Six inflammatory biomarkers in peripheral blood (white blood cells (WBC) count and CRP, IL-6, IL-8, fibrinogen and TNF-α levels) were quantified in 1,755 COPD patients, 297 smokers with normal spirometry and 202 non-smoker controls that were followed-up for three years. We found that, at baseline, 30% of COPD patients did not show evidence of systemic inflammation whereas 16% had persistent systemic inflammation. Even though pulmonary abnormalities were similar in these two groups, persistently inflamed patients during follow-up had significantly increased all-cause mortality (13% vs. 2%, p